FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

María Teresa Valenzuela

Research Profile

Geographic Areas

Chemicals & Drugs

Procedures

Physiology

Microbial Drug Resistance

Disorders

Living Beings

Concepts & Ideas

Drug Administration Schedule

Co-author Network

Publications

TOP 3
María Elena Santolaya; Daniela Toneatto; María Teresa Valenzuela; Rodrigo Vergara; Huajun Wang; Ralf Clemens; Peter M Dull; Gabriela Graña; Alma Muñoz; Miguel O'Ryan; Valeria Prado
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study.
Dagna Constenla; Anushua Sinha; Juan Esteban Valencia; Elizabeth Gomez; Fernando de la Hoz; María Teresa Valenzuela; Ciro A de Quadros
Identifying unit costs for use in regional economic evaluation: an illustrative analysis of childhood pneumococcal conjugate vaccine in Latin America and the Caribbean.
María Teresa Valenzuela; Rosalyn O'Loughlin; Fernando De La Hoz; Elizabeth Gomez; Dagna Constenla; Anushua Sinha; Juan Esteban Valencia; Brendan Flannery; Ciro A de Quadros
The burden of pneumococcal disease among Latin American and Caribbean children: review of the evidence.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of María Teresa Valenzuela (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: María Elena Santolaya; Daniela Toneatto; María Teresa Valenzuela; Rodrigo Vergara; Huajun Wang; Ralf Clemens; Peter M Dull; Gabriela Graña; Alma Muñoz; Miguel O'Ryan; Valeria Prado
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study.
Lancet 2012;379(9816):617-24.
2009: Dagna Constenla; Anushua Sinha; Juan Esteban Valencia; Elizabeth Gomez; Fernando de la Hoz; María Teresa Valenzuela; Ciro A de Quadros
Identifying unit costs for use in regional economic evaluation: an illustrative analysis of childhood pneumococcal conjugate vaccine in Latin America and the Caribbean.
Revista panamericana de salud pública = Pan American journal of public health 2009;26(5):458-68.
2009: María Teresa Valenzuela; Rosalyn O'Loughlin; Fernando De La Hoz; Elizabeth Gomez; Dagna Constenla; Anushua Sinha; Juan Esteban Valencia; Brendan Flannery; Ciro A de Quadros
The burden of pneumococcal disease among Latin American and Caribbean children: review of the evidence.
Revista panamericana de salud pública = Pan American journal of public health 2009;25(3):270-9.
2008: Katia Abarca; María Teresa Valenzuela; Rodrigo Vergara; Vivian Luchsinger; Alma Muñoz; Jorge Jiménez de la J; Erna Ripoll; Miguel O'Ryan
[Human papillomavirus vaccine. Statement of the Advisory Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008].
Revista médica de Chile 2008;136(11):1485-92.
2008: Anushua Sinha; Dagna Constenla; Juan Esteban Valencia; Rosalyn O'Loughlin; Elizabeth Gomez; Fernando de la Hoz; María Teresa Valenzuela; Ciro A de Quadros
Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis.
Revista panamericana de salud pública = Pan American journal of public health 2008;24(5):304-13.
2007: María Teresa Valenzuela; Rogelio H Altuzarra; Olivia A Trucco; Rodrigo R Villegas; Jaime S Inostroza; Paulo S Granata; José V Fleiderman; Leonardo C Maggi
Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in elderly residents of a long-term care facility.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2007;11(3):322-6.
2005: Alejandro Corvalán; suminori akiba; María Teresa Valenzuela; Miguel Angel Cumsille; Chihaya Koriyama; Jorge Argandoña; Claudia Backhouse; Matilde Bal; Fernando Mena; Mariana Palma; Yoshito Eizuru
[Clinical and molecular features of cardial gastric cancer associated to Epstein Barr virus].
Revista médica de Chile 2005;133(7):753-60.
2002: Rosanna Lagos; Alma Muñoz; María Teresa Valenzuela; Ingrid Heitmann; Myron M Levine
Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile.
The Pediatric infectious disease journal 2002;21(12):1115-23.
1999: María Teresa Valenzuela; J Vega; I Leal; M Vicente; V Young; L Vera; R Fasce; E Ramírez
[Immune status against measles and rubella among 4 Chilean groups of different ages].
Revista médica de Chile 1999;127(3):359-65.
1998: María Teresa Valenzuela; X Ferrer; I Leal; M Pacheco; N Castillo; F Cumsille
[Comparative study of the efficacy of two types of BCG vaccines administered in different doses].
Revista médica de Chile 1998;126(9):1126-31.
1998: Rosanna Lagos; María Teresa Valenzuela; Orin S Levine; Genevieve A Losonsky; A Erazo; Steven Wasserman; Myron M Levine
Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens.
Lancet 1998;351(9114):1472-6.
1995: A Yáñez; M Bachelet; María Teresa Valenzuela; P Valenzuela; A Henríquez; R Child
[HIV infection and its effects on tuberculosis endemic in Chile].
Boletín de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 1995;119(2):166-78.
1994: L Castillo; A Maldonado; J García; W Silva; M T Ulloa; María Teresa Valenzuela; R Bustos; M E Valenzuela; M P Gassibe
[Characterization of Neisseria meningitidis isolated fron systemic infections. Chile, 1992-1993].
Revista médica de Chile 1994;122(7):760-7.
1993: A M Guzmán; P García; María Teresa Valenzuela; S Piffardi; R Lepe; M Velasco; M I Vergara
[Acquired resistance of M tuberculosis to the antitubercular drugs in Chile from 1988 to 1991].
Revista médica de Chile 1993;121(11):1269-73.
1992: R Guarda; W Gubelin; J Gajardo; I Rohmann; María Teresa Valenzuela
[Cutaneous infection by mycobacterium marinum: case report].
Revista médica de Chile 1992;120(9):1027-32.
1989: María Teresa Valenzuela; P Garcia; J Ponce; R Lepe; M Velasco; S Piffardi
Drug resistance of M. tuberculosis in Chile: rates of initial resistance for 1986 and acquired resistance for 1985.
Bulletin of the International Union against Tuberculosis and Lung Disease 1989;64(2):13-4.
1989: B Gonzalez; S Moreno; R Burdach; María Teresa Valenzuela; A Henriquez; M I Ramos; R U Sorensen
Clinical presentation of Bacillus Calmette-Guérin infections in patients with immunodeficiency syndromes.
The Pediatric infectious disease journal 1989;8(4):201-6.
1988: P Valenzuela; María Teresa Valenzuela; J Ponce
Response to short-course chemotherapy of patients with initial resistance to antituberculosis drugs.
Bulletin of the Pan American Health Organization 1988;22(2):175-83.
1986: V Farga; P Valenzuela; María Teresa Valenzuela; G Schell; A Lagos; A Nuñez; R Soto; M Fernández; D Araya
[Short-term chemotherapy of tuberculosis with 5-month regimens with and without pyrazinamide in the 2d phase (TA-82)].
Revista médica de Chile 1986;114(7):701-5.
1984: V Farga; P Valenzuela; A Yañez; María Teresa Valenzuela; G Scheel; F Mendoza; E Torres; I Icekson; M Grinspun; M Fernández
[Short-course treatment of tuberculosis on a 7-month schedule with an initial intensive phase of 1 month (TA-81)].
Revista médica de Chile 1984;112(3):290-5.
1984: P Valenzuela; María Teresa Valenzuela
[Short-course chemotherapy for tuberculosis in Chile. Operational considerations].
Revista médica de Chile 1984;112(3):287-9.
1984: María Teresa Valenzuela; G Scheel; J Ponce; R Lepe; M Velasco; P Valenzuela
[Resistance to antitubercular drugs in Chile].
Revista médica de Chile 1984;112(1):76-80.
1983: V Farga; P Valenzuela; A Yañez; María Teresa Valenzuela; G Scheel; F Mendoza; E Torres; I Icekson; M Grinspun; M Fernández
[Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].
Revista médica de Chile 1983;111(7):750-4.